Weight Loss SA

Medications offered

As listed on the provider’s own site. Whether a product is FDA-approved or compounded is the single most important distinction here — we explain why.

• SemaglutideType not stated

What they publish

Weight Loss SA publishes 2 of 12 standard terms. Fields marked “not publicly disclosed” were not stated on the pages we captured, and we have not filled those gaps with assumptions. Compare disclosure across providers

Membership / programme fee

$49 doctor visit published, including a free two-week trial of semaglutide 0.25mg (as published)

Medication cost

Published at $75 for a four-week supply at 0.25mg, rising to $150-$200 at higher doses (as published)

Introductory offer

Free two-week semaglutide trial with the $49 doctor visit

Insurance

Not publicly disclosed on the pages we captured.

HSA / FSA

Not publicly disclosed on the pages we captured.

Consultation process

Not publicly disclosed on the pages we captured.

Eligibility

Not publicly disclosed on the pages we captured.

Lab work

Not publicly disclosed on the pages we captured.

Pharmacy fulfilment

Not publicly disclosed on the pages we captured.

Shipping

Not publicly disclosed on the pages we captured.

Support services

Not publicly disclosed on the pages we captured.

Cancellation

Not publicly disclosed on the pages we captured.

Refunds

Not publicly disclosed on the pages we captured.

What stands out

• A free medication trial is unusual and worth thinking about carefully — a two-week supply at the lowest dose tells you about tolerability, not about outcomes.
• Publishes the dose escalation clearly: $75 at 0.25mg rising to $150-$200 at higher doses.
• San Antonio focused.

Questions to ask before you pay

These are things we could not settle from published pages, or that we think are easy to misread. Get answers in writing.

• A free trial is a customer-acquisition device; the cost that matters is at maintenance dose.
• Two weeks at the starting dose will not tell you whether the treatment works for you.
• Ask whether the semaglutide is FDA-approved or compounded.